$114.50
+0.77%Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
Moderate conversion rate. Some gap between earnings and cash flow may warrant investigation into working capital or non-cash items.
Declining FCF warrants attention. Investigate whether due to temporary factors or fundamental deterioration.
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโmonitor closely.
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
AFL โข NYSE
| Aflac Incorporated Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
3.6B | 5.4B | 4.7B | 4.4B | 4.2B | 4.8B | 3.3B | 2.9B | 4.6B | 2.7B | 2.5B | 3B | 3.2B | 2.9B | 1.9B | 2.3B | 1.5B | 1.3B | 1.6B | 1.5B | |
341M | -2.1B | 183M | -761M | -122M | 518M | 323M | 742M | -35M | 48M | 608M | 94M | 2M | 211M | 1.7B | 325M | 1.5B | 1.2B | 37M | -55M | |
(0.0) | (1.4B) | (1.6B) | (961M) | (880M) | (800M) | (1.4B) | (998M) | (780M) | (1.5B) | (996M) | (1.4B) | (754M) | (788M) | (828M) | (1B) | (627M) | (765M) | (416M) | (0.0) | |
-1.4B | -644M | -1.7B | 222M | 942M | 662M | 1.8B | 2.4B | 1.6B | 3.3B | 3.6B | 3.5B | 7.4B | 11.9B | 7.2B | 4.3B | 3.2B | 2.5B | 3B | 3B | |
2.6B | 2.7B | 3.2B | 3.9B | 5.1B | 6B | 5.5B | 6B | 6.1B | 6B | 6.8B | 6.6B | 10.5B | 15B | 10.8B | 7B | 6.2B | 5B | 4.7B | 4.4B | |
INVESTING ACTIVITIES | ||||||||||||||||||||
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -49M | -46M | -23M | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -40M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -83M | (0.0) | (0.0) | (0.0) | |
-14B | -7.1B | -3.6B | -4.3B | -7.4B | -6.1B | -7.9B | -10.2B | -11.1B | -10.8B | -9.2B | -14.9B | -31.7B | -36.1B | -27.4B | -12.3B | -11.7B | -8B | -6.8B | -7.4B | |
13.7B | 8B | 4.3B | 5B | 4.6B | 4B | 6.6B | 10B | 7.8B | 8.5B | 5.8B | 13.9B | 19.6B | 13.2B | 16B | 5.2B | 7.6B | 3.1B | 3.2B | 3.1B | |
1.9B | 1.9B | 95M | -2.3B | 369M | -2.5B | -1.8B | -3.4B | -2.1B | -1.5B | -1.5B | -3.2B | 1B | 6B | 585M | -340M | -1.3B | 657M | -32M | 190M | |
(1.6B) | (2.8B) | (817M) | -1.5B | -2.4B | -4.6B | -3.2B | -3.6B | -5.4B | -3.9B | -4.9B | -4.2B | -11.1B | -17B | -10.8B | -7.4B | -5.5B | -4.3B | -3.7B | -4.1B | |
FINANCING ACTIVITIES | ||||||||||||||||||||
-3.5B | -2.8B | -2.8B | -2.4B | -2.3B | -1.5B | -1.6B | -1.2B | -1.3B | -1.4B | -1.3B | -1.2B | -725M | -86M | -282M | -76M | 7M | -1.5B | -559M | -428M | |
955M | 629M | 204M | -139M | 453M | 1.2B | 615M | 470M | -121M | 376M | -274M | 415M | 700M | 1.2B | 158M | 297M | 845M | -5M | -5M | 5M | |
-1.2B | -1.1B | -966M | -979M | -855M | -769M | -771M | -793M | -661M | -658M | -656M | -654M | -635M | -603M | -552M | -535M | -524M | -434M | -373M | -258M | |
-3.5B | -2.8B | -2.8B | -2.4B | -2.3B | -1.5B | -1.6B | -1.3B | -1.4B | -1.4B | -1.3B | -1.2B | -813M | -118M | -308M | -121M | -10M | -1.5B | -606M | -470M | |
-304M | -242M | -177M | -49M | -62M | -38M | 21M | -50M | 35M | 39M | 22M | 1.3B | 1.8B | 1.5B | 740M | 475M | 371M | 514M | 282M | 247M | |
-4.1B | -3.5B | -3.7B | -3.6B | -2.7B | -1.1B | -1.7B | -1.6B | -2.1B | -1.6B | -2.2B | -147M | 1.1B | 1.9B | 64M | 161M | 699M | -1.4B | -655M | -434M | |
CASH FLOW SUMMARY | ||||||||||||||||||||
-31M | -79M | 79M | 104M | -24M | 21M | -12M | 30M | 0.0 | -4M | 0.0 | -47M | -90M | -153M | 51M | 80M | -2M | 79M | 13M | 0.0 | |
16M | 1.9B | 363M | -1.1B | -90M | 245M | 559M | 846M | -1.4B | 509M | -308M | 2.1B | 502M | -208M | 128M | -202M | 1.4B | -622M | 360M | -94M | |
6.2B | 4.3B | 3.9B | 5.1B | 5.1B | 4.9B | 4.3B | 3.5B | 4.9B | 4.4B | 4.7B | 2.5B | 2B | 2.2B | 2.1B | 2.3B | 941M | 1.6B | 1.2B | 1.3B | |
6.2B | 6.2B | 4.3B | 3.9B | 5.1B | 5.1B | 4.9B | 4.3B | 3.5B | 4.9B | 4.4B | 4.7B | 2.5B | 2B | 2.2B | 2.1B | 2.3B | 941M | 1.6B | 1.2B | |
2.6B | 2.7B | 3.2B | 3.9B | 5.1B | 6B | 5.5B | 6B | 6.1B | 6B | 6.8B | 6.6B | 10.5B | 15B | 10.8B | 7B | 6.2B | 5B | 4.7B | 4.4B |
AFL - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 28, 2026 | May 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 14, 2026 | May 11, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 04, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 06, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 29, 2026 | April 29, 2026 | 2026 | |
S-3 S-3 N/A | April 23, 2026 | April 23, 2026 | ย | |
DEF 14A DEF 14A 2026 N/A | March 19, 2026 | May 04, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 25, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 04, 2026 | February 04, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 05, 2025 | September 30, 2025 | 2025 |
Continue your AFL research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.